InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.08), $0.03 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $477 thousand versus the consensus estimate of $850 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.